Liid Pharmaceuticals, Inc.
- Biotech or pharma, therapeutic R&D
Liid Pharmaceutical, Inc. is a pre-clinical stage company and committed to develop antisense oligonucleotides (ASOs) by leveraging our proprietary BROTHERS technology which thermodynamically and kinetically enhances the efficacy and mitigates safety profiles by reducing off-target effects. Our lead indications are focused on CNS diseases such as Gaucher's disease (lysosomal storage diseases), epilepsy, ALS, and cardiovascular diseases. FIH study is expected in 2027.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}